Delivery Order SPE2DB24D2100-SPE2DB26FBAHX
- Not listed
- The Defense Logistics Agency awarded a $1,221.69 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Qulipta 30 mg tablets (30-count). The contract utilizes firm fixed-price pricing with no set-aside designation and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,547.07 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Qulipta 60 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,568.63. This non-set-aside competitive award is scheduled for completion by September 2, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract valued at $1,649.05. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order without set-aside designation. AmerisourceBergen will perform this contract from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,036.88 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count units) on September 17, 2025, with completion scheduled for September 18, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,154.79 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,471.33 to supply Qulipta 60 mg tablets (30-count packages) for delivery to the company's Conshohocken, Pennsylvania headquarters. This competitively awarded, firm fixed-price contract was executed on June 17, 2025, with an ultimate completion date of June 18, 2025, and carries no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (quantity 30) under a firm fixed-price contract valued at $3,592.48. The order was competitively awarded without set-aside designation and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in the same...
- The Defense Logistics Agency awarded a $4,047.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Qulipta 60 mg tablets in quantities of 30. This non-competitive delivery order, with a completion date of April 24, 2025, will be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count) under a firm fixed-price contract valued at $10,801.96, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive procurement of pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB26FBAHXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) valued at $3,530.41 with a firm fixed price and no set-aside designation. The award was issued on October 17, 2025, with an ultimate completion date of October 20, 2025. Performance will take place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The parent IDC enables the company to deliver brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded with firm fixed pricing structures, demonstrating the company's capability to meet federal procurement requirements and serve as a key supplier within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 10/17/25 |